Author

Akiko Shigemasa

Institutions: Kyoto University, Center for iPS Cell Research and Application, Kyoto University

Observed institutions: Kyoto University, Center for iPS Cell Research and Application, Kyoto University

OpenAlex ID: A5089629980

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

2022 · Naoshi Sugimoto, Junya Kanda, et al. · Blood · 105

Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial

2022 · Naoshi Sugimoto, Sou Nakamura, et al. · Blood Advances · 51

The First-in-Human Clinical Trial of iPSC-Derived Platelets (iPLAT1): Autologous Transfusion to an Aplastic Anemia Patient with Alloimmune Platelet Transfusion Refractoriness

2021 · Naoshi Sugimoto, Junya Kanda, et al. · Blood · 9

Works count: 3

Citation count: 165

H-index: 3

I10-index: 2